MY130771A - 3-azabicyclo [3.1.0] hexane derivatives useful in therapy. - Google Patents

3-azabicyclo [3.1.0] hexane derivatives useful in therapy.

Info

Publication number
MY130771A
MY130771A MYPI99005067A MYPI9905067A MY130771A MY 130771 A MY130771 A MY 130771A MY PI99005067 A MYPI99005067 A MY PI99005067A MY PI9905067 A MYPI9905067 A MY PI9905067A MY 130771 A MY130771 A MY 130771A
Authority
MY
Malaysia
Prior art keywords
azabicyclo
therapy
derivatives useful
hexane derivatives
opiate
Prior art date
Application number
MYPI99005067A
Inventor
Bernard Joseph Banks
Robert James Crook
Stephen Paul Gibson
Graham Lunn
Alan John Pettman
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9828485.4A external-priority patent/GB9828485D0/en
Priority claimed from GBGB9912425.7A external-priority patent/GB9912425D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of MY130771A publication Critical patent/MY130771A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

COMPOUNDS OF FORMULA (I) , THEIR SALTS AND PRODRUGS THEREOF, WHERE THE SUBSTITUENTS ARE AS DEFINED HEREIN ARE DISCLOSED AS OPIATE BINDING AGENTS USEFUL IN THE TREATMENT OF OPIATE-MEDIATED CONDITIONS. ALSO DESCRIBED ARE PROCESSES FOR MAKING SUCH SUBSTANCES.
MYPI99005067A 1998-12-23 1999-11-19 3-azabicyclo [3.1.0] hexane derivatives useful in therapy. MY130771A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828485.4A GB9828485D0 (en) 1998-12-23 1998-12-23 Compounds useful in therapy
GBGB9912425.7A GB9912425D0 (en) 1999-05-27 1999-05-27 Compounds useful in therapy

Publications (1)

Publication Number Publication Date
MY130771A true MY130771A (en) 2007-07-31

Family

ID=40257194

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99005067A MY130771A (en) 1998-12-23 1999-11-19 3-azabicyclo [3.1.0] hexane derivatives useful in therapy.

Country Status (10)

Country Link
KR (1) KR100504647B1 (en)
AR (1) AR035157A1 (en)
CO (1) CO5261495A1 (en)
IL (1) IL142697A (en)
MY (1) MY130771A (en)
PA (1) PA8488001A1 (en)
PE (1) PE20001318A1 (en)
PT (1) PT1140828E (en)
RS (1) RS50051B (en)
TN (1) TNSN99235A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007137954A1 (en) 2006-05-31 2007-12-06 F. Hoffmann-La Roche Ag Aryl-4-ethynyl-isoxazole derivatives

Also Published As

Publication number Publication date
PE20001318A1 (en) 2000-12-01
RS50051B (en) 2008-11-28
AR035157A1 (en) 2004-05-05
TNSN99235A1 (en) 2005-11-10
PA8488001A1 (en) 2002-10-28
KR20010086462A (en) 2001-09-12
KR100504647B1 (en) 2005-07-29
PT1140828E (en) 2006-12-29
YU41501A (en) 2004-03-12
CO5261495A1 (en) 2003-03-31
IL142697A (en) 2009-05-04

Similar Documents

Publication Publication Date Title
AP1852A (en) '3-Azabicyclo{3.1.0] hexane derivatives as opiate receptors ligands.
BG105270A (en) Tetrahydropyridoethers
MXPA02008056A (en) 2 oxo 1 pyrrolidine derivatives, processes for preparing them and their uses.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
MY121047A (en) Bicyclo [2.2.1] heptanes and related compounds
AU5377698A (en) Substituted pyrrolyl compounds for the treatment of inflammation
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
AP9701041A0 (en) Pyridylpyrrole compounds.
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
MX9503529A (en) Glycinamide derivatives, process for their preparation and medicaments containing them.
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
DE69907419D1 (en) Antitumorwirkstoffe
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MX9700807A (en) N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics.
BG105008A (en) Hygromycin a derivatives
MY130771A (en) 3-azabicyclo [3.1.0] hexane derivatives useful in therapy.
YU46302A (en) Substituted pyrroles
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof
WO2005030148A3 (en) Tetrahydroindolone derivatives for treatment of neurological conditions
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
AU2178199A (en) Azetidinecarboxamide derivatives for the treatment of cns disorders
AU2796695A (en) Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders
HK1082727A1 (en) 2" oxo-voruscharin and derivatives thereof